INL – International Iberian Nanotechnology Laboratory and its spin-off RUBYnanomedhave just been awarded the prestigious Caixa Impulse Consolidate funds to help the fight against cancer. INL and RUBYnanomed solution is to provide non-invasive patient monitoring using our technology for a liquid biopsy that automatically isolates and classifies cancer cells that are in circulation. These circulating tumour cells, or CTCs, are responsible for the metastasis process, and their analysis provides real-time information about cancer progression, enabling the prediction of disease aggressiveness and resistance to therapy